Breckenridge Pharmaceutical announces final FDA approval for Dehydrated Alcohol Injection, USP (generic for Ablysinol®)
Berkeley Heights, New Jersey, June 24, 2025 Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, announced today that the Food and Drug Administration (FDA) has granted approval of its Dehydrated Alcohol Injection, USP, 5 mL of ≥ 99% by volume ethyl alcohol Single-Dose […]
